C
GMED icon

Cerebellum’s Globus Medical GMED Stock Holding History

Cerebellum’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$64K Buy
+1,299
New +$67K 0.3% 130
2019
Q4 		$398K Buy
+6,758
New +$367K 0.21% 319
2019
Q3 		– Sell
-322
Closed -$14K – 456
2019
Q2 		$14K Buy
+322
New +$14K 0.01% 403

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Cerebellum's GMED Position: Q3 2020 in Review

Cerebellum opened a new position in Globus Medical (GMED) in Q3 2020: 1,299 shares worth $64K. The stake represents 0.3% of the portfolio and ranks #130 among its holdings. This is a return to the name: Cerebellum previously reported a position in GMED as recently as Q4 2019.

Cerebellum first reported a position in GMED in Q2 2019 and has held it in 3 quarters since. The position peaked at $398K in Q4 2019. 343 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • Cerebellum held 1,299 shares of Globus Medical worth $64K as of Q3 2020.
  • Globus Medical was a new Cerebellum position in Q3 2020.
  • Globus Medical made up 0.3% of Cerebellum's portfolio in Q3 2020, its #130 holding.
  • Cerebellum first reported a position in Globus Medical in Q2 2019 and has held it in 3 quarters since.
  • Cerebellum's Globus Medical position peaked at $398K in Q4 2019.
  • 343 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.